Article
Determination of Risk Factors Associated with the Failure of 12 Weeks of Direct-Acting…
BioMed Research International · 2021 · Phuong Nguyen Thi Thu, author Mai Ngo Thi Quynh, author Linh Pham Van, author Hung Nguyen Van, author Hoi Nguyen Thanh, author Fu-Ming Tsai, Academic Editor
Key facts
| Title | Determination of Risk Factors Associated with the Failure of 12 Weeks of Direct-Acting Antiviral Therapy in Patients with Hepatitis C: A Prospective Study |
|---|---|
| First author | Phuong Nguyen Thi Thu, author Mai Ngo Thi Quynh, author Linh Pham Van, author Hung Nguyen Van, author Hoi Nguyen Thanh, author Fu-Ming Tsai, Academic Editor |
| Journal | BioMed Research International |
| Published | Oct 15, 2021 |
| DOI | 10.1155/2022/6054677 |
| Devices mentioned | K103302 |
| Product codes mentioned | MVU, NJT, OOI, NDS |
At a glance
- 1–9 FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1